BioSpace News Archive

Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs, announced that it has filed its 2021 first quarter report. The Report shows that the Company had Cash & Cash Equivalents of $1,796,596 as of March 31, 2021, the period end.

Equillium, Inc., a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, announced that an abstract highlighting positive data from the EQUATE study of itolizumab in acute graft-versus-host disease has been accepted for oral presentation at EHA2021 Virtual Congress.

Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), is focused on integrating human-powered scientific and technology-based systems to de-risk and accelerate the discovery and development of preclinical and clinical pipelines for biopharma partners as well as for the proprietary pipeline of the Company. Today, Vyant Bio announced that an investor conference call and webcast will be hosted on Tuesday, May 18, 2021.

Heron Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has approved ZYNRELEF

Reistone Biopharma Company Limited (Reistone), a clinical stage biopharmaceutical company focused on developing novel medicines for autoimmune and inflammatory diseases, today announced the first patient has been dosed in their Phase III, global clinical trial (RSJ10333) of SHR0302,

LIPAC Oncology LLC., a pharmaceutical company utilizing its liposome-bound nano-technology platform to provide precision targeted cancer drugs for the treatment of multiple tumor types, today announced the appointment of Daniel K. Spiegelman as an independent board advisor.

Eurofins Covid Testing Services Ltd are now officially an approved government provider for day 2 and day 8 PCR testing.

Dow announced that five leaders earned recognition on three 2021 EMpower Ethnic Minority Role Model lists, including Top 20 Advocates, 100 Ethnic Minority Executives, and 100 Ethnic Minority Future Leaders.

Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announced a Q1 2021 increase in revenue of 61% in its operating division on a year-over-year basis. In addition, the sales team has recorded the opening of five new customer accounts utilizing BVA and reports a growing pipeline of additional acquisitions of Daxor’s BVA-100 Blood Volume Analyzer slated for Q3 2021

Transcat, Inc., a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced the appointments of Craig D. Cairns and Mbago M. Kaniki to its Board of Directors, effective May 12, 2021.